Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Keymed Biosciences (2162 HK)
Watchlist
65
Analysis
Health Care
•
Hong Kong
Keymed Biosciences Inc. operates a biotechnology company. The Company focus on the in-house discovery and development of innovative biological therapies. Keymed Biosciences provides services in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
18 Mar 2024 08:55
Important New Policy for China’s Innovative Drugs – The Game Rule Is About to Change Radically
A new document about China's innovative drugs would change the game rule/outlook radically. We have reasons to start being optimistic that the...
Xinyao (Criss) Wang
Follow
299 Views
Share
bearish
•
Quantitative Analysis
•
28 Jan 2024 10:20
Hong Kong Connect Flows (Jan 26th): Tencent
We analyzed southbound Hong Kong connect flows in the past week and highlight southbound Hong Kong connect flows for Tencent.
Ke Yan, CFA, FRM
Follow
362 Views
Share
bearish
•
Quantitative Analysis
•
21 Jan 2024 10:20
Hong Kong Connect Flows (Jan 19th): CCB
We analyzed southbound Hong Kong connect flows in the past week and highlight southbound Hong Kong connect flows for CCB.
Ke Yan, CFA, FRM
Follow
441 Views
Share
bearish
•
Quantitative Analysis
•
14 Jan 2024 10:20
Hong Kong Connect Flows (Jan 12th): CNOOC, Tencent
Highlight: We analyzed southbound Hong Kong connect flows in the past week and highlight Hong Kong connect flows for CNOOC, Tencent.
Ke Yan, CFA, FRM
Follow
383 Views
Share
bullish
•
Thematic (Sector/Industry)
•
02 Jan 2024 08:55
China's Rising Role in Global ADC Partnership Wave - Opportunities and Risks Behind the Gold Rush
As China's ADCs continue to gain recognition from global buyers,the position of Chinese pharmaceutical companies is undergoing fundamental...
Xinyao (Criss) Wang
Follow
482 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.2
x